Abstract Body

Background: Malignancies in people with HIV are a major cause of morbidity and mortality. With improving control of HIV infection, the burden and complexities of malignancies are increasing.
Methods: Recent publications and public data were reviewed, focusing on international patterns and differences between AIDS-defining cancers (ADC) and non-ADC.
Results: In the USA, the incidence and burden (total number of cases) of malignancies fell dramatically from 1993-1998, but this was exclusively ADC, specifically Kaposi sarcoma (KS) and non-Hodgkin lymphoma (NHL). Since 1998, age-adjusted incidence has been stable while burden of non-ADC has increased. From 2012-2015, ADC incidence increased 5-10% outside North America and Europe. Southern and especially east Africa continue to have the highest burden of KS. Cervix cancer has had the highest incidence and burden especially in Africa, but most cases do not have HIV. Aging is increasing the importance of ADC, the most important of which are cancers of the lung, anus and liver. Lung cancer is by far the most common ADC, but incidence fell from 1996-2010, perhaps due to smoking reduction. Anus and liver cancers are increasing, probably due to longer survival with HPV and HCV, respectively. Hodgkin lymphoma is decreasing, probably with better control of HIV. Mortality due to NADC has been increasing in most populations.
Conclusions: Implementation of programs to address malignancies are needed, especially in low and middle-income countries. Global access and use of effective antiretroviral therapy is paramount, but research is needed to integrate and optimize combined antiretroviral and cancer therapies. Reducing the burden of cervix and anus cancers will require global access and use of HPV vaccines, but VIA with simplified HPV screening could be a useful interim approach. Liver cancer burden would be reduced with broader use of HBV vaccine and HCV direct-acting agents. Smoking cessation is needed to reduce the morbidity and mortality from lung cancer and many other diseases.